|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Trikafta Levels
Test Code13805
CPT Codes
80299<br>Restricted Client Code<br><strong>This test is not available for New York patient testing</strong>
Preferred Specimen
2 mL serum collected in a red-top tube (no gel)
Minimum Volume
0.25 mL
Other Acceptable Specimens
Plasma collected in a (green-top) tube
Instructions
Allow to clot for 30 minutes, separate serum from cells immediately by centrifugation and aliquot into a labeled polypropylene or similar plastic tube. Use a separate tube for each test ordered. Allow room for expansion of sample inside tube.
Transport Temperature
Frozen
Specimen Stability
Room temperature: 24 hours
Refrigerate: Unacceptable
Frozen -20° C: 7 days
Frozen -70° C: 1 year
Refrigerate: Unacceptable
Frozen -20° C: 7 days
Frozen -70° C: 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum separator tube (SST) • Severe hemolysis • Thawed samples for greater than 24 hours
Methodology
HPLC-UV
FDA Status
The performance characteristics for this test have been validated by Advanced Diagnostic Laboratories at National Jewish Health. It has not been cleared or approved by the US Food and Drug Administration. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88) as qualified to perform high complexity clinical laboratory testing.
Setup Schedule
Set up: Varies; Report available:10 days
Reference Range
Tezacaftor: 6 - 9.4 mcg/mL
Ivacaftor: 0.9 - 1.5 mcg/mL
Elexacaftor: 7.1 - 11.3 mcg/mL
Ivacaftor: 0.9 - 1.5 mcg/mL
Elexacaftor: 7.1 - 11.3 mcg/mL
Clinical Significance
This test is a high performance liquid chromatography drug monitoring assay that detects levels of elexacaftor, tezacaftor, ivacaftor and two metabolites (M1-IVA, M6-IVA) from a clinical serum specimen. The test is intended to enhance the precision and effectiveness of Trikafta therapy by tailoring the treatment to individual patients, optimizing dosages, mitigating side effects, monitoring treatment response, and offering valuable data for clinical decision-making.